Table 4.
Changes in plasma biomarkers during WL (Phase 1).
| Variable | Men (n = 21) | Women (n = 19) | Total (n = 40) | |
|---|---|---|---|---|
| Glucose (mg/dL) | Week 0 | 103.3 ± 5.0 | 96.4 ± 3.3 | 99.8 ± 3.0 |
| Week 12 a | 91.3 ± 2.1 | 89.8 ± 2.3 | 90.5 ± 1.5 | |
| Insulin (μU/mL) | Week 0 | 9.2 ± 1.1 | 6.0 ± 0.5 | 7.6 ± 0.7 |
| Week 12 a | 5.5 ± 0.8 | 3.5 ± 0.3 | 4.5 ± 0.5 | |
| Leptin (ng/mL) | Week 0 | 13.6 ± 1.7 | 84.7 ± 17.7 | 45.4 ± 9.8 |
| Week 12 a | 6.6 ± 1.3 | 22.9 ± 3.5 | 13.9 ± 2.1 | |
| Adiponectin (ng/mL) | Week 0 | 16.1 ± 2.1 | 27.8 ± 5.3 | 21.7 ± 2.9 |
| Week 12 | 15.7 ± 1.6 | 27.3 ± 4.3 | 21.2 ± 2.3 |
Values are means ± SE; a Significant time effect (week 0 vs. week 12), p < 0.05.